What is Orphan Drug?
Orphan Drug
An orphan drug is a medication developed specifically to treat rare diseases, which affect a small number of patients. These drugs often receive special incentives from governments to encourage their development, as the market for them is limited.
Overview
Orphan drugs are designed to treat rare medical conditions, often referred to as orphan diseases. These diseases typically affect fewer than 200,000 people in the United States, making it financially challenging for pharmaceutical companies to develop treatments. As a result, many patients with these conditions have limited or no treatment options available. The development of orphan drugs is supported by various incentives such as tax credits, grants, and extended market exclusivity, which help to offset the costs and risks involved in bringing these drugs to market. The process of creating an orphan drug begins with identifying a rare disease and understanding its underlying biology. Researchers then work on developing a drug that can effectively target the disease. For instance, the drug Eteplirsen was developed to treat Duchenne Muscular Dystrophy, a rare genetic disorder. By providing a targeted treatment, orphan drugs can significantly improve the quality of life for patients who have few alternatives. The importance of orphan drugs extends beyond individual patients; they play a crucial role in advancing medical research and understanding rare diseases. By focusing on these conditions, researchers can uncover new insights that may also benefit broader therapeutic areas. As the field of pharmacology continues to evolve, orphan drugs highlight the need for innovation in addressing unmet medical needs, ultimately contributing to the overall advancement of healthcare.